|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
22 April 2024 |
|
Main ID: |
NCT02969915 |
|
Date of registration:
|
18/11/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Strategies to Improve the HIV Care Continuum Among Key Populations in India
|
|
Scientific title:
|
Strategies to Improve the HIV Care Continuum Among Key Populations in India |
|
Date of first enrolment:
|
October 30, 2017 |
|
Target sample size:
|
2314 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02969915 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
India
| | | | | | | |
|
Contacts
|
|
Name:
|
Gregory M Lucas, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Johns Hopkins University |
|
|
Name:
|
Shruti H Mehta, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Johns Hopkins University |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Speaks Hindi, English, or local language
- HIV-positive
- Antiretroviral therapy (ART) naive or has used ART less than 12 months
- Registered client at the local integrated care center (ICC), which serves either
people who inject drugs (PWID) or men who have sex with men (MSM).
Exclusion Criteria:
- Not competent to provide informed consent or participate in the study.
- Receives HIV care in the private sector
- Plans to migrate in next 12 months
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
HIV Infections
|
|
Intervention(s)
|
|
Behavioral: Incentives
|
|
Behavioral: Integrated Care Centers
|
|
Primary Outcome(s)
|
|
Proportion of Participants Surviving With Viral Suppression
[Time Frame: 12 months]
|
|
Secondary Outcome(s)
|
|
Retention to HIV Care
[Time Frame: 12 months]
|
|
Proportion of Participants With Viral Suppression at One or More Follow-up Visits
[Time Frame: 24 months]
|
|
ART Adherence
[Time Frame: 12 months]
|
|
Antiretroviral Therapy (ART) Initiation
[Time Frame: 12 months]
|
|
Mortality
[Time Frame: 12 months]
|
|
Proportion of Participants Surviving With Viral Suppression
[Time Frame: 18 months]
|
|
Proportion of Participants Surviving With Viral Suppression
[Time Frame: 6 months]
|
|
Proportion of Participants Surviving With Viral Suppression
[Time Frame: 24 months]
|
|
Secondary ID(s)
|
|
K24DA035684
|
|
IRB00082575
|
|
R01DA041034
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|